KIORA PHARMACEUTICALS INC

KPRX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 13 employees
260
SEC Filings
$2.55
Close 2026-09-03
13
Employees

Business Summary

Kiora Pharmaceuticals is a clinical-stage specialty pharmaceutical company developing therapies for retinal diseases. Its lead asset, KIO-301, is a small-molecule photoswitch designed to restore vision in patients with retinitis pigmentosa and other degenerative retinal diseases. KIO-104 is a DHODH inhibitor formulated for intravitreal delivery targeting diabetic macular edema and posterior non-infectious uveitis. KIO-101, the same active compound as KIO-104 in topical form, targets ocular manifestations of autoimmune diseases.

Latest Stock Quote

KPRX 2026-09-03 $2.55 O:$2.63 H:$2.66 L:$2.55 Vol:0.0M VWAP:$2.5889
origin leaf: null

Next Earnings

expected 2026-11-18

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-252025-12-310001372514-26-000024EDGAR65K words
2025-03-252024-12-310001372514-25-000012EDGAR62K words
2024-03-252023-12-310001372514-24-000026EDGAR59K words
2023-03-232022-12-310001372514-23-000050EDGAR61K words
2022-04-152021-12-310001410578-22-000925EDGAR—
2021-03-252020-12-310001104659-21-041515EDGAR—
2020-03-042019-12-310001104659-20-029162EDGAR—
2019-03-012018-12-310001144204-19-011634EDGAR—
2018-03-022017-12-310001144204-18-012542EDGAR—
2017-02-232016-12-310001144204-17-010635EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-072026-06-300001372514-26-000074EDGAR20K words
2025-11-072025-09-300001372514-25-000078EDGAR19K words
2025-08-082025-06-300001372514-25-000061EDGAR19K words
2025-05-092025-03-310001372514-25-000044EDGAR17K words
2024-11-082024-09-300001372514-24-000120EDGAR20K words
2024-08-092024-06-300001372514-24-000104EDGAR19K words
2024-05-102024-03-310001372514-24-000053EDGAR16K words
2023-11-092023-09-300001372514-23-000158EDGAR21K words
2023-08-082023-06-300001372514-23-000117EDGAR19K words
2023-05-092023-03-310001372514-23-000069EDGAR16K words
2022-11-092022-09-300001410578-22-003035EDGAR20K words
2022-08-122022-06-300001410578-22-002336EDGAR17K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-080001372514-26-000079EDGAR1K words
2026-08-190001372514-26-000077EDGAR1K words
2026-08-070001372514-26-000075EDGAR3K words
2026-04-020001372514-26-000028EDGAR1K words
2026-03-250001372514-26-000025EDGAR3K words
2025-11-070001372514-25-000079EDGAR3K words
2025-08-130001372514-25-000068EDGAR1K words
2025-08-080001372514-25-000064EDGAR3K words
2025-06-040001372514-25-000053EDGAR1K words
2025-06-030001372514-25-000050EDGAR1K words

260 total filings indexed. 228 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

retinitis-pigmentosa inherited-retinal-diseases diabetic-macular-edema posterior-non-infectious-uveitis ocular-presentation-of-rheumatoid-arthritis-and-autoimmune-diseases geographic-atrophy

Company Identity

CIK0001372514
TickerKPRX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
Websitehttps://www.kiorapharma.com
Listed2015-02-13

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 2f793b68065ec12c8227ffbe216e8dd724d38a014b53b2683a8955607b494718
parent: c50be1a32b3c94451412574d6e76f26059adc6a3dd9201119b32e92427c15a8f
content hash: fd6a5268442703d6fa8f4ab8456a541800d1d0ca34eac22a57e7443c77e17f50
signed: 2026-09-30T19:02:05.636Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up KPRX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on KPRX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/KPRX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.